CLDF Title
Home | Contact Us | Bookmark
HEPATITIS
HBV HCV HDV
CLD HEALTH OUTCOMES
CIRRHOSIS
CIRRHOSIS HEPATIC ENCEPHALOPATHY (HE) HEPATORENAL SYNDROME (HRS) THROMBOCYTOPENIA
NASH
CHOLESTATIC
PRIMARY BILIARY CHOLANGITIS (PBC)
HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
About CLDF
Board of Trustees Board of Advisors/Faculty CLDF Committees 2023 GI Fellow Board of Advisors
Embassy of Education
Slide Library Webcasts Annotations Abstract Library Committee Members
 
HBV-Single Disease Content  
Featured Article


Webcasts
     
HBV/HDV-ACT Connect (ADVANCING CURATIVE TREATMENTS)   Educational Webcast
Hepatitis B and D Infection   Educational Webcast
HBV/HDV Hot Topics & Virtual Roundtable   Educational Webcast
HBV, HCV, and HDV   Educational Webcast
 
 
Slide Library
   Released: 2023
Webcast
Stopping All Therapy in HBV Clinical Trials: What Should Be the Criteria for Discontinuation
23 slides
 
 
   Released: 2023
Webcast
New Insights Into The Biology Of HDV: Implications For Drug Development
42 slides
 
 
   Released: 2023
Webcast
HBV Overview of the Last 3 Years For Drug Development: Phase 2 Trials
43 slides
 
 
   Released: 2023
Webcast
Emerging Therapies for HBV in the Next Three Years (Pre-clinical to Phase 1)
31 slides
 
 
   Released: 2023
Webcast
What Are the Most Promising Immunomodulatory Therapies for HBV Infection?
29 slides
 
 
   Released: 2023
Webcast
Emerging Concepts and Data CpAMS Third and Fourth Generation
33 slides
 
 
   Released: 2023
Webcast
Does the New Data on HBV DNA Integration and HBsAg Production Effect the Design and Definition of Treatment Endpoints of Phase II and Phase III Studies?
20 slides
 
 
   Released: 2023
Webcast
Is there a real difference between ETV and TDF/TAF in relapse and HCC?
27 slides
 
 
   Released: 2023
Webcast
How Do We Fit FNA and Liver Biopsy Into HBV Drug Development and Design? Should All Studies Have FNA Subset and Examine Intrahepatic Immune Activity? CccDNA? Integrants?
19 slides
 
 
   Released: 2023
Webcast
Should All Patients With HDV Be Treated?
22 slides
 
 
   Released: 2023
Webcast
HDV Update: Review of the Last 3 Years
18 slides
 
 
   Released: 2023
Webcast
Hepatitis Delta: How Should Bulevirtide Be Used in Clinical Practice
27 slides
 
 
   Released: 2023
Webcast
What Other Therapies Are Being Developed for HDV Infection? NAPS, Lambda, and Lonafarnib
36 slides
 
 
   Released: 2023
Webcast
What Is the Role of Interferon Therapy in HDV?
30 slides
 
 
   Released: 2021
Webcast
HBV Alliance: Expert Recommendations on Managing Patients with Chronic Hepatitis B
56 slides
 
 
   Released: 2021
Webcast
Acute HBV
17 slides
 
 
   Released: 2021
Webcast
Chemotherapy/Reactivation
26 slides
 
 
   Released: 2021
Webcast
Current Management of Chronic Hepatitis B
30 slides
 
 
   Released: 2021
Webcast
Epidemiology of HBV
34 slides
 
 
   Released: 2021
Webcast
Evaluation of the Patient With Chronic HBV
26 slides
 
 
   Released: 2021
Webcast
Everything Old Is New Again!
41 slides
 
 
   Released: 2021
Webcast
Extrahepatic Manifestations of Hepatitis B
34 slides
 
 
   Released: 2021
Webcast
HBsAg Quant HBV Genotyping HBV RNA Quant Where We Are in 2020
41 slides
 
 
   Released: 2021
Webcast
HBV & Hepatitis D (Delta)
26 slides
 
 
   Released: 2021
Webcast
HBV and Liver Cancer
34 slides
 
 
   Released: 2021
Webcast
HBV and NAFLD
35 slides
 
 
   Released: 2021
Webcast
HBV Coinfection With HCV or HIV
35 slides
 
 
   Released: 2021
Webcast
HBV: New Therapies & Clinical Trials
37 slides
 
 
   Released: 2021
Webcast
Hepatitis B Screening: CDC, AASLD, USPSTF
24 slides
 
 
   Released: 2021
Webcast
Hepatitis B: Treatment Endpoints
27 slides
 
 
   Released: 2021
Webcast
Hepatitis B: Update on Treatment Guidelines
27 slides
 
 
   Released: 2021
Webcast
How to Diagnose Hepatitis B
25 slides
 
 
   Released: 2021
Webcast
Immunization for HBV
31 slides
 
 
   Released: 2021
Webcast
Management of HBV: New Data
26 slides
 
 
   Released: 2021
Webcast
Natural History of HBV
39 slides
 
 
   Released: 2021
Webcast
Treatment of Hepatitis B: Controversies 2020
63 slides
 
 
   Released: 2021
Webcast
Update on Hepatitis B
54 slides
 
 
   Released: 2021
Webcast
WHO Hepatitis Elimination Targets
46 slides
 
 
   
     
 
 
 
Annotated Bibliography
1.Safety, Tolerability And Antiviral Activity Of The Antisense Oligonucleotide Bepirovirsen In Patients With Chronic Hepatitis B: A Phase 2 Randomized Controlled Trial
 

Nat Med. 2021 Oct;27(10):1725-1734. doi: 10.1038/s41591-021-01513-4.Epub 2021 Oct 12.

Man-Fung Yuen 1, Jeong Heo 2, Jeong-Won Jang 3, Jung-Hwan Yoon 4, Young-Oh Kweon 5, Sung-Jae Park 6, Yvonne Tami 7, Shihyun You 8, Phillip Yates 9, Yu Tao 8, Jennifer Cremer 10, Fiona Campbell 9, Robert Elston 9, Dickens Theodore 10, Melanie Paff 8, C Frank Bennett 7, T Jesse Kwoh 7
 
2.Critical Updates on Chronic Hepatitis B Virus Infection in 2021
 

Cureus. 2021 Oct 30;13(10):e19152. doi: 10.7759/cureus.19152.eCollection 2021 Oct.

Cyriac A Philips 1, Rizwan Ahamed 2, Jinsha K Abduljaleel 2, Sasidharan Rajesh 3, Philip Augustine 2
 
3.New Treatments for Chronic Hepatitis B Virus/Hepatitis D Virus Infection
 

Clin Liver Dis. 2021 Nov;25(4):831-839. doi: 10.1016/j.cld.2021.06.011.Epub 2021 Aug 8.

Lisa Sandmann 1, Heiner Wedemeyer 2
 
4.Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
 

Lok AS1, Zoulim F2, Dusheiko G3, Chan HLY4, Buti M5, Ghany MG6, Gaggar A7, Yang JC7, Wu G7, Flaherty JF7, Subramanian GM7, Locarnini S8, Marcellin P9. Hepatol Commun. 2019 Oct 10;4(1):8-20. doi: 10.1002/hep4.1436. eCollection 2020 Jan.
 
 
 
 
Abstract Library
1.Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
 

Lancet Gastroenterol Hepatol. 2023 Oct;8(10):879-907. doi: 10.1016/S2468-1253(23)00197-8.Epub 2023 Jul 27.

 
 
2.Hepatitis B Virus and B-cell lymphoma: evidence, unmet need, clinical impact, and opportunities
 

Front Oncol. 2023 Oct 20:13:1275800. doi: 10.3389/fonc.2023.1275800.eCollection 2023.

 

Maya Rosenberg 1 2, Maria Poluch 2, Colin Thomas 3 4, Paola Sindaco 4 5, Alan Khoo 4, Pierluigi Porcu 4 5
 
3.Strategies for Hepatitis B Virus Prevention in People Living with HIV
 

Curr HIV/AIDS Rep. 2023 Oct 14. doi: 10.1007/s11904-023-00670-0.Online ahead of print.

 

Maria A Corcorran 1, H Nina Kim 2
 
4.Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data
 

BMC Gastroenterol. 2023 Oct 25;23(1):366.doi: 10.1186/s12876-023-02996-w.

 

Dong Hyun Sinn # 1 2, Danbee Kang # 2 3, Yewan Park 4, Hyunsoo Kim 3, Yun Soo Hong 5, Juhee Cho 6 7 8, Geum-Youn Gwak 9
 
5.Pegylated interferon-a for chronic hepatitis B…not ready to be shelved yet! new insights on its role using single-cell transcriptomics
 

Hepatology. 2023 Sep 1. doi: 10.1097/HEP.0000000000000560. Online ahead of print.

 

Upkar S Gill 1, Dimitra Peppa 2

 
 
6.Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants
 

Hepatol Commun. 2023 Jul 17;7(8):e0188.doi: 10.1097/HC9.0000000000000188. eCollection 2023 Aug 1.

 

Alexander J Thompson 1 2, Kathy Jackson 3, Sara Bonanzinga 3, Sam A L Hall 1 2, Simon Hume 1 2, Gareth S Burns 1 2, Vijaya Sundararajan 2 4, Dilip Ratnam 5 6, Miriam T Levy 7, John Lubel 8 9, Amanda J Nicoll 10, Simone I Strasser 11 12, William Sievert 5 6, Paul V Desmond 1, Meng C Ngu 13, Marie Sinclair 14, Christopher Meredith 15, Gail Matthews 16, Peter A Revill 3, Margaret Littlejohn 3, D Scott Bowden 3, Jesse A Canchola 17, Jason Torres 17, Philip Siew 18, Jasmin Lau 17, Benjamin La Brot 17, Alison Kuchta 17, Kumar Visvanathan 3
 
7.An Assessment of National Strategic Action Plans for Viral Hepatitis Elimination, 2016-2021
 

J Infect Dis. 2023 Sep 13;228(Suppl 3):S148-S153. doi: 10.1093/infdis/jiad346.

 

Henry N Njuguna 1, Lindsey Hiebert 1, Angelique Harris 1 2, Rebecca L Morgan 3 4, Neil Gupta 1, John W Ward 1
 
8.Sex-differences in the association of interleukin-10 and interleukin-12 variants with the progression of hepatitis B virus infection in Caucasians
 

Hepatol Res. 2023 Aug 10. doi: 10.1111/hepr.13952. Online ahead of print.

 

Janett Fischer 1, Eleni Koukoulioti 1 2, Tobias Müller 3, Renate Heyne 4, Mohammed Eslam 5, Jacob George 5, Fabian Finkelmeier 6, Oliver Waidmann 7, Thomas Berg 1, Florian van Bömmel 1
 
9.Change in Health-related Quality of Life in Youth with Chronic Hepatitis B Living in North America:A 5-year Cohort Study
 

J Pediatr Gastroenterol Nutr. 2023 Sep 27. doi: 10.1097/MPG.0000000000003957.Online ahead of print.

 

Sarah Jane Schwarzenberg 1, Wendy C King 2, Simon C Ling 3, Karen F Murray 4, Douglas Mogul 5, Philip Rosenthal 6, Norberto Rodriguez-Baez 7, Jeffrey Teckman 8, Kathleen B Schwarz 9; Hepatitis B Research Network (HBRN)
 
10.Design and analysis considerations for early phase clinical trials in hepatitis B (HBV) cure research: the ACTG A5394 study in persons with both HIV and HBV
 

 Virus Erad. 2023 Aug 24;9(3):100344. doi: 10.1016/j.jve.2023.100344. eCollection 2023 Sep.

 

Minhee Kang 1, Jennifer C Price 2, Marion G Peters 3, Sharon R Lewin 4 5 6, Mark Sulkowski 7
 
11.Comparison of HBV DNA and RNA markers in Alaska Native people who did and did not clear hepatitis B surface antigen
 

J Viral Hepat. 2023 Sep;30(9):727-730. doi: 10.1111/jvh.13867. Epub 2023 Jun 22.

 

Janet M Johnston 1, Brian McMahon 1, Brenna C Simons 1, Chriss Homan 1
 
12.Routine blood test markers for predicting liver disease post HBV infection: precision pathology and pattern recognition
 

Diagnosis (Berl). 2023 Sep 20. doi: 10.1515/dx-2023-0078. Online ahead of print.

 

Busayo I Ajuwon 1 2, Katrina Roper 1, Alice Richardson 3, Brett A Lidbury 1
 
13.Chronic hepatitis B and HIV coinfection
 

Top Antivir Med. 2023 Mar 31;31(1):14-22.

 

Maria A Corcorran 1, Nina Kim 1
 
14.Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillance
 

Vox Sang. 2023 Sep 11. doi: 10.1111/vox.13514. Online ahead of print.

 

Syria Laperche 1 2, Claire Sauvage 3, Pierre Gallian 1, Saadia Jbilou 1, Elodie Pouchol 1, Jean Yves Py 1, Lila Chabli 1, Pascale Richard 1, Pascal Morel 1 4, Florence Lot 3, Pierre Tiberghien 1 4
 
15.High prevalence of hepatitis A and B nonimmunity in pediatric liver transplant recipients
 

Clin Transplant. 2023 Aug;37(8):e15035. doi: 10.1111/ctr.15035. Epub 2023 Jun 2.

 

Annabelle de St Maurice 1, G Ng 2, C Aryasomayajula 3, A Liman 4, S V McDiarmid 5, R S Venick 5, Laura J Wozniak 6
 
16.Training the healthcare workforce: the global experience with telementorship for hepatitis B and hepatitis C
 

BMC Health Serv Res. 2023 Aug 2;23(1):824. doi: 10.1186/s12913-023-09849-y.

 

Maria A Corcorran 1 2, Karla Thornton 3 4, Bruce Struminger 3 4, Philippa Easterbrook 5, John D Scott 6
 
17.Efficacy of Hepatitis B Vaccine in Adults with Chronic Liver Disease
 

J Pharm Pract. 2023 Aug;36(4):839-844. doi: 10.1177/08971900221078742. Epub 2022 Feb 24.

 

Yaeji Kim 1, Jennifer Loucks 2, Meera Shah 3
 
18.Chronic Hepatitis B Finite Treatment: similar and different concerns with new drug classes
 

Clin Infect Dis. 2023 Aug 26;ciad506. doi: 10.1093/cid/ciad506. Online ahead of print.

 

Marion G Peters 1, Man-Fung Yuen 2, Norah Terrault 3, John Fry 4, Pietro Lampertico 5, Ed Gane 6, Carey Hwang 7, Luisa M Stamm 8, Mitchell Leus 9, Mala K Maini 10, Patricia Mendez 11, Isabelle Lonjon-Domanec 12, Thomas Berg 13, Su Wang 14, Poonam Mishra 15, Eric Donaldson 15, Stephanie Buchholz 16, Veronica Miller 9, Oliver Lenz 17
 
19.Who Is at Risk for New Hepatitis B Infections Among People With HIV?
 

Open Forum Infect Dis. 2023 Jul 17;10(8):ofad375. doi: 10.1093/ofid/ofad375.eCollection 2023 Aug.

 

John M Sladic 1, Barbara S Taylor 1, Mae Thamer 2, Karen J Vigil 3, Onkar Kshirsagar 2, Anna Taranova 1, Andrew McCracken 1, Carmen G Sanchez 4, Mamta K Jain 5 6
 
20.IFN-?: A Crucial Player in the Fight Against HBV Infection?
 

Immune Netw. 2023 Jun 15;23(4):e30. doi: 10.4110/in.2023.23.e30.eCollection 2023 Aug.

 

Marine Laure Bettina Hillaire 1, Philip Lawrence 1, Brice Lagrange 1
 
21.Enhancing interventions for prevention of mother-to-child- transmission of hepatitis B virus
 

JHEP Rep. 2023 Apr 24;5(8):100777. doi: 10.1016/j.jhepr.2023.100777.eCollection 2023 Aug.

 

Philippa C Matthews 1 2 3, Ponsiano Ocama 4, Su Wang 5 6, Manal El-Sayed 7, Anna Turkova 8, Deborah Ford 8, Judith Torimiro 9 10, Ana Cristina Garcia Ferreira 11, Angélica Espinosa Miranda 11, Fernando Pio De La Hoz Restrepo 12, Emmanuel Seremba 4, Robinson Mbu 10, Calvin Q Pan 13, Homie Razavi 14, Geoffrey Dusheiko 15, C Wendy Spearman 16, Saeed Hamid 17
 
22.Chronic Hepatitis B Infection: New Approaches towards Cure
 

Biomolecules. 2023 Aug 1;13(8):1208. doi: 10.3390/biom13081208.

 

Mojisola Ogunnaike 1 2, Srijanee Das 1 2, Samiksha S Raut 1, Ashrafi Sultana 1, Mohammad Ullah Nayan 1, Murali Ganesan 1 3, Benson J Edagwa 1, Natalia A Osna 1 3, Larisa Y Poluektova 1
 
23.Global burden of hepatitis B virus: current status, missed opportunities and a call for action
 

Nat Rev Gastroenterol Hepatol. 2023 Aug;20(8):524-537.doi: 10.1038/s41575-023-00760-9. Epub 2023 Apr 6.

 

Yao-Chun Hsu 1 2 3 4, Daniel Q Huang 5 6, Mindie H Nguyen 7 8
 
24.Real-World Use of Immunotherapy for Hepatocellular Carcinoma
 

Pragmat Obs Res. 2023 Aug 21;14:63-74. doi: 10.2147/POR.S397972.eCollection 2023.

 

Amir Sara 1, Samantha M Ruff 2, Anne M Noonan 1, Timothy M Pawlik 2
 
25.Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance
 

Clin Gastroenterol Hepatol. 2023 Jul;21(7):1957-1959. doi: 10.1016/j.cgh.2022.06.019.Epub 2022 Jul 16.

 

Wendy C King 1, Richard K Sterling 2, Amanda S Hinerman 3, Anna S F Lok 4, Gavin A Cloherty 5, Marc G Ghany 6; HBRN HBV NOVELASSAYS GROUP

 

Collaborators

  • HBRN HBV NOVELASSAYS GROUP: 

Abdus S Wahed 7, Raymond T Chung 8, Harry L A Janssen 9, Mandana Khalili 10, Daryl T Y Lau 11, William M Lee 12, Mauricio Lisker-Melman 13, Norah Terrault 14
 
View More
 
 

HEPATITIS

HBV
HCV
HDV

CLD HEALTH OUTCOMES

CIRRHOSIS

Cirrhosis
HE
HRS
Thrombocytopenia

NASH

Slide Library
Publications
Webcasts
Abstract Library Committee Members

CHOLESTATIC

PBC

HCC

Slide Library
Publications
Webcasts
Algorithm
Abstract Library Committee Members

ALCOHOL LIVER DISEASE

Recorded Educational Webinar

PEDIATRIC LIVER DISEASE

Webcasts
Slide Library
Abstract Library

About CLDF

Board of Trustees
Board of Advisors/Faculty
CLDF Committees
2023 GI Fellow Board of Advisors

Other Resources

Journal Abstracts

Subscribe

Be the first to know about our latest upcoming programs and events!
CLDF

Follow us
Facebook
Twitter
Youtube
LiverQ
The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2023 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.